Award Symposium: The LCGC Lifetime Achievement and Emerging Leader Awards
For the first time this year, the winners of the LCGC Awards will be honored in an oral symposium at Pittcon. Jack Kirkland of Advanced Materials Technology will receive the 2015 LCGC Lifetime Achievement Award at 1:30, and Caroline West, of the University of Orléans, will receive the 2015 LCGC Emerging Leader Award at 3:40 pm, just after the break.
For the first time this year, the winners of the LCGC Awards will be honored in an oral symposium at Pittcon. Jack Kirkland of Advanced Materials Technology will receive the 2015 LCGC Lifetime Achievement Award at 1:30, and Caroline West, of the University of Orléans, will receive the 2015 LCGC Emerging Leader Award at 3:40 pm, just after the break. The symposium will be held in room 244 this afternoon
Following the presentation of the Lifetime Achievement Award, Kirkland will give a talk on tools to improve protein separations. Mark Schure of Kroungould Analytical will then discuss where the crossover point lies between one- and two-dimensional LC. Rounding out the first part of the program, Lloyd Snyder will give a presentation on the hydrogen-bond basicity of reversed-phase columns.
After receiving the Emerging Leader Award, West will discuss “The New Face of Supercritical Fluid Chromatography (SFC): Why Analysts Should Take Another Look.” Terry Berger of SFC Solutions will then discuss why more academic researchers and teachers are needed in SFC.
Read about Kirkland and West in the article in our February issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
